High Vascular Tone of Mouse Femoral Arteries In Vivo Is Determined by Sympathetic Nerve Activity Via α1A- and α1D-Adrenoceptor Subtypes

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Zacharia, Joseph ^a   Mauban, Joseph R H ^a   Raina, Hema ^a   Fisher, Steven A ^a   Wier, Withrow G ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 ETHYLSULFONYL 5,8,8A,9,10,11,12,12A,13,13A DECAHYDRO 3 METHOXY 6H ISOQUINO[2,1 G][1,6]NAPHTHYRIDINE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CHLOROETHYLCLONIDINE; HEXAMETHONIUM; MYOSIN LIGHT CHAIN KINASE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y RECEPTOR; NPY1 RECEPTOR; PRAZOSIN; PURINERGIC P2X RECEPTOR; SURAMIN; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; BIOSENSOR; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; FLUORESCENCE MICROSCOPY; IN VIVO STUDY; INTRAVITAL FLUORESCENCE MICROSCOPY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BLOCKING; SYMPATHETIC NERVE;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC FIBERS; ANIMALS; ARGININE; CALCIUM; FEMORAL ARTERY; ISOQUINOLINES; MICE; MICROSCOPY, FLUORESCENCE; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; MYOGRAPHY; MYOSIN-LIGHT-CHAIN KINASE; NAPHTHYRIDINES; PIPERAZINES; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-1; SURAMIN; THYMINE;

ANIMALIA; MUS;

EID: 84878953378     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065969     Document Type: Article

References (53)

1. Kuroki MT, Guzman PA, Fink GD, Osborn JW, (2012) Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG II-salt hypertension. Am J Physiol Heart Circ Physiol 302: H763-769.
2. Huggett RJ, Burns J, Mackintosh AF, Mary DA, (2004) Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 44: 847-852.
3. Parati G, Esler M, (2012) The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J 33: 1058-1066.
4. Wier WG, Zang WJ, Lamont C, Raina H, (2009) Sympathetic neurogenic Ca2+ signalling in rat arteries: ATP, noradrenaline and neuropeptide Y. Exp Physiol. 94: 31-37.
5. Rummery NM, Brock JA, Pakdeechote P, Ralevic V, Dunn WR, (2007) ATP is the predominant sympathetic neurotransmitter in rat mesenteric arteries at high pressure. J Physiol 582: 745-754.
6. Tarasova O, Sjoblom-Widfeldt N, Nilsson H, (2003) Transmitter characteristics of cutaneous, renal and skeletal muscle small arteries in the rat. Acta Physiol Scand 177: 157-166.
7. Docherty JR, (2010) Subtypes of functional α1-adrenoceptor. Cell Mol Life Sci 67: 405-417.
8. Hieble JP, Ruffolo RR Jr, (1996) Subclassification and nomenclature of α1- and α2-adrenoceptors. Prog Drug Res 47: 81-130.
9. Flavahan NA, Vanhoutte PM, (1986) α1-Adrenoceptor subclassification in vascular smooth muscle. Trends in Pharmacological Sciences 7: 347-349.
10. Muramatsu I, Kigoshi S, Oshita M, (1990a) Two distinct α1-adrenoceptor subtypes involved in noradrenaline contraction of the rabbit thoracic aorta. Br J Pharmacol 101: 662-666.
11. Muramatsu I, Ohmura T, Kigoshi S, Hashimoto S, Oshita M, (1990b) Pharmacological subclassification of α1-adrenoceptors in vascular smooth muscle. Br J Pharmacol 99: 197-201.
12. Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, et al. (1997) Pharmacological pleiotropism of the human recombinant α1A-adrenoceptor: implications for α1-adrenoceptor classification. Br J Pharmacol 121: 1127-1135.
13. Muramatsu I, Morishima S, Suzuki F, Yoshiki H, Anisuzzaman AS, et al. (2008) Identification of α1L-adrenoceptor in mice and its abolition by α1A-adrenoceptor gene knockout. Br J Pharmacol 155: 1224-1234.
14. Rokosh DG, Simpson PC, (2002) Knockout of the α1A/C-adrenergic receptor subtype: the α1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci U S A 99: 9474-9479.
15. Tanoue A, Nasa Y, Koshimizu T, Shinoura H, Oshikawa S, et al. (2002) The α1D-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest 109: 765-775.
16. Hosoda C, Hiroyama M, Sanbe A, Birumachi J, Kitamura T, et al. (2007) Blockade of both α1A- and α1B-adrenergic receptor subtype signaling is required to inhibit neointimal formation in the mouse femoral artery. Am J Physiol Heart Circ Physiol 293: H514-519.
17. Lyssand JS, DeFino MC, Tang XB, Hertz AL, Feller DB, et al. (2008) Blood pressure is regulated by an α1D-adrenergic receptor/dystrophin signalosome. J Biol Chem 283: 18792-18800.
18. Daly CJ, Deighan C, McGee A, Mennie D, Ali Z, et al. (2002) A knockout approach indicates a minor vasoconstrictor role for vascular α1B-adrenoceptors in mouse. Physiol Genomics 9: 85-91.
19. Zacharia J, Hillier C, Tanoue A, Tsujimoto G, Daly CJ, et al. (2005) Evidence for involvement of α1D-adrenoceptors in contraction of femoral resistance arteries using knockout mice. Br J Pharmacol 146: 942-951.
20. Townsend SA, Jung AS, Hoe YS, Lefkowitz RY, Khan SA, et al. (2004) Critical role for the α1B-adrenergic receptor at the sympathetic neuroeffector junction. Hypertension 44: 776-782.
21. Moore AW, Jackson WF, Segal SS, (2010) Regional heterogeneity of α-adrenoreceptor subtypes in arteriolar networks of mouse skeletal muscle. J Physiol 588: 4261-4274.
22. Methven L, Simpson PC, McGrath JC, (2009) α1A/B-knockout mice explain the native α1D-adrenoceptor's role in vasoconstriction and show that its location is independent of the other α1-subtypes. Br J Pharmacol 158: 1663-1675.
23. Isotani E, Zhi G, Lau KS, Huang J, Mizuno Y, et al. (2004) Real-time evaluation of myosin light chain kinase activation in smooth muscle tissues from a transgenic calmodulin-biosensor mouse. Proc Natl Acad Sci U S A 101: 6279-6284.
24. Wier WG, Rizzo MA, Raina H, Zacharia J, (2008) A technique for simultaneous measurement of Ca2+, FRET fluorescence and force in intact mouse small arteries. J Physiol 586: 2437-2443.
25. Zhang J, Chen L, Raina H, Blaustein MP, Wier WG, (2010) In vivo assessment of artery smooth muscle [Ca2+]i and MLCK activation in FRET-based biosensor mice. Am J Physiol Heart Circ Physiol 299: H946-956.
26. Mauban JR, Zacharia J, Zhang J, Wier WG, (2013) Vascular tone and Ca2+ signaling in murine cremaster muscle arterioles in vivo. Microcirculation 20: 269-277.
27. Cambridge D, Davey MJ, Massingham R, (1977) Prazosin, a selective antagonist of post-synaptic α-adrenoceptors [proceedings]. Br J Pharmacol 59: 514P-515P.
28. Williams TJ, Blue DR, Daniels DV, Davis B, Elworthy T, et al. (1999) In vitro α1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel α1A-adrenoceptor selective antagonists. Br J Pharmacol 127: 252-258.
29. Goetz AS, King HK, Ward SD, True TA, Rimele TJ, et al. (1995) BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors. Eur J Pharmacol 272: R5-6.
30. Bautista DL, Morris DH, Stein L, Asher W, Hammitt T, (2006) A two model receptor system of the α1D adrenergic receptor to describe interactions with epinephrine and BMY7378. J Chem Inf Model 46: 334-344.
31. Han C, Abel PW, Minneman KP, (1987) α1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle. Nature 329: 333-335.
32. Jarajapu YP, Hillier C, MacDonald A, (2001) The α1A-adrenoceptor subtype mediates contraction in rat femoral resistance arteries. Eur J Pharmacol 422: 127-135.
33. Mulvany MJ, Halpern W, (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41: 19-26.
34. Zhang H, Fisher SA, (2007) Conditioning effect of blood flow on resistance artery smooth muscle myosin phosphatase. Circ Res 100: 730-737.
35. Zacharia J, Hillier C, MacDonald A, (2004) α1-adrenoceptor subtypes involved in vasoconstrictor responses to exogenous and neurally released noradrenaline in rat femoral resistance arteries. Br J Pharmacol 141: 915-924.
36. Arunlakshana O, Schild HO, (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14: 48-58.
37. Schild HO, (1949) pAx and competitive drug antagonism. Br J Pharmacol Chemother 4: 277-280.
38. Davis MJ, Hill MA, (1999) Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79: 387-423.
39. Reimann K, Krishnamoorthy G, Wier WG, Wangemann P, (2011) Gender differences in myogenic regulation along the vascular tree of the gerbil cochlea. PLoS One 6: e25659.
40. Geary GG, Krause DN, Duckles SP, (1998) Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries. Am J Physiol 275: H292-300.
41. Ibrahim J, McGee A, Graham D, McGrath JC, Dominiczak AF, (2006) Sex-specific differences in cerebral arterial myogenic tone in hypertensive and normotensive rats. Am J Physiol Heart Circ Physiol 290: H1081-1089.
42. Crassous PA, Flavahan S, Flavahan NA, (2009) Acute dilation to α2-adrenoceptor antagonists uncovers dual constriction and dilation mediated by arterial α2-adrenoceptors. Br J Pharmacol 158: 1344-1355.
43. Marti D, Miquel R, Ziani K, Gisbert R, Ivorra MD, et al. (2005) Correlation between mRNA levels and functional role of α1-adrenoceptor subtypes in arteries: evidence of α1L as a functional isoform of the α1A-adrenoceptor. Am J Physiol Heart Circ Physiol 289: H1923-1932.
44. Fujimoto S, (1994) α1-adrenoceptor subtypes mediating contraction of the femoral artery in spontaneously hypertensive rats. Can J Physiol Pharmacol 72: 862-869.
45. Tsurumaki T, Honglan P, Higuchi H, (2003) Neuropeptide Y selectively potentiates α1-adrenoceptor-mediated contraction through Y1 receptor subtype in rat femoral artery. J Cardiovasc Pharmacol 42Suppl 1: S33-37.
46. Stam WB, Van der Graaf PH, Saxena PR, (1999) Analysis of α1L-adrenoceptor pharmacology in rat small mesenteric artery. Br J Pharmacol 127: 661-670.
47. Schwinn DA, Page SO, Middleton JP, Lorenz W, Liggett SB, et al. (1991) The α1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity. Mol Pharmacol 40: 619-626.
48. Yang M, Reese J, Cotecchia S, Michel MC, (1998) Murine α1-adrenoceptor subtypes. I. Radioligand binding studies. J Pharmacol Exp Ther 286: 841-847.
49. Hirasawa A, Sugawara T, Awaji T, Tsumaya K, Ito H, et al. (1997) Subtype-specific differences in subcellular localization of α1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface α1-adrenoceptors irrespective of the subtype. Mol Pharmacol 52: 764-770.
50. Lopez-Guerrero JJ, Ibarra M, Villalobos-Molina R, (2005) Postjunctional α1-adrenoceptors in the vasculature of the pithed mouse are of the α1A-subtype. Auton Autacoid Pharmacol 25: 101-103.
51. Taki N, Tanaka T, Zhang L, Suzuki F, Israilova M, et al. (2004) α1D adrenoceptors are involved in reserpine-induced supersensitivity of rat tail artery. Br J Pharmacol 142: 647-656.
52. Piascik MT, Hrometz SL, Edelmann SE, Guarino RD, Hadley RW, et al. (1997) Immunocytochemical localization of the α1B-adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. J Pharmacol Exp Ther 283: 854-868.
53. Ziani K, Gisbert R, Noguera MA, Ivorra MD, D'Ocon P, (2002) Modulatory role of a constitutively active population of α1D-adrenoceptors in conductance arteries. Am J Physiol Heart Circ Physiol 282: H475-481.